AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 15 filers reported holding AKARI THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $510 | -6.1% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $543 | -61.4% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,407 | -29.6% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 3,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +20.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -28.6% | 3,000 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 3,000 | -7.6% | 0.00% | – |
| Q1 2020 | $5,000 | 0.0% | 3,246 | +8.2% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -77.3% | 3,000 | +99.5% | 0.00% | – |
| Q4 2015 | $22,000 | – | 1,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |